Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study-Reference-Cited by-同舟云学术

Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study

Published:2023-03 Issue: Volume:71 Page:104548
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Barzegar Mahdi^ORCID,Manteghinejad Amirreza,Afshari-Safavi Alireza,Mirmosayyeb Omid,Nasirian Maryam,Bagherieh Sara,Mazaheri Shahrbanoo,Rahimi Maryam,zabeti Aram,Javanmard Shaghayegh Haghjooy,Shaygannejad Vahid

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference52 articles.

1. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales;Agrawal;Lancet,2022

2. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2· 57 million people in Scotland (EAVE II): a prospective cohort study;Agrawal;Lancet Respir. Med.,2021

3. Impact of the Sinopharm's BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE);AlHosani;Vaccine,2022

4. Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates;Al Kaabi;Nat. Commun.,2022

5. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial;Al Kaabi;JAMA,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cq values as an indicator for COVID‐19 outcomes: A study of the correlation between laboratory parameters;Immunity, Inflammation and Disease;2024-06

2. COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece;Journal of Clinical Medicine;2023-08-23